| 000 | 01819 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250513185456.0 | ||
| 264 | 0 | _c19990901 | |
| 008 | 199909s 0 0 eng d | ||
| 022 | _a0007-1188 | ||
| 024 | 7 |
_a10.1038/sj.bjp.0702601 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCunha, F Q | |
| 245 | 0 | 0 |
_aPharmacological modulation of secondary mediator systems--cyclic AMP and cyclic GMP--on inflammatory hyperalgesia. _h[electronic resource] |
| 260 |
_bBritish journal of pharmacology _cJun 1999 |
||
| 300 |
_a671-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBradykinin _xpharmacology |
| 650 | 0 | 4 |
_aCarrageenan _xpharmacology |
| 650 | 0 | 4 |
_aCyclic AMP _xmetabolism |
| 650 | 0 | 4 |
_aCyclic GMP _xmetabolism |
| 650 | 0 | 4 |
_aDinoprostone _xpharmacology |
| 650 | 0 | 4 |
_aDopamine _xpharmacology |
| 650 | 0 | 4 |
_aHyperalgesia _xchemically induced |
| 650 | 0 | 4 |
_aInflammation _xchemically induced |
| 650 | 0 | 4 |
_aInterleukin-1 _xpharmacology |
| 650 | 0 | 4 |
_aInterleukin-6 _xpharmacology |
| 650 | 0 | 4 |
_aInterleukin-8 _xpharmacology |
| 650 | 0 | 4 |
_aIsoquinolines _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aOxadiazoles _xpharmacology |
| 650 | 0 | 4 |
_aPhosphodiesterase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aPyrrolidinones _xpharmacology |
| 650 | 0 | 4 |
_aQuinoxalines _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 | _aRolipram |
| 650 | 0 | 4 |
_aSecond Messenger Systems _xdrug effects |
| 650 | 0 | 4 | _aSulfonamides |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xpharmacology |
| 700 | 1 | _aTeixeira, M M | |
| 700 | 1 | _aFerreira, S H | |
| 773 | 0 |
_tBritish journal of pharmacology _gvol. 127 _gno. 3 _gp. 671-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.bjp.0702601 _zAvailable from publisher's website |
| 999 |
_c10359788 _d10359788 |
||